van Seters A P, van Aalderen W, Moolenaar A J, Gorsiro M C, van Roon F, Backer E T
Clin Endocrinol (Oxf). 1981 Apr;14(4):325-34. doi: 10.1111/j.1365-2265.1981.tb00617.x.
Data are presented concerning a 60-year-old woman with untreated congenital adrenocortical hyperplasia due to 21-hydroxylase deficiency, who presented with a tumour of the left adrenal gland. Steroid excretion was partly suppressed with dexamethasone. After removal of the tumour, the excretion of several steroid fractions decreased substantially, but suppression by dexamethasone remained inadequate. Preoperatively, plasma ACTh was elevated in the afternoon and decreased only slightly after dexamethasone administration. After surgery, cortisol secretion decreased markedly, whereas ACTH dysregulation became more prominent. Negative feedback failure precluded the use of normal suppressive therapy with low doses of glucocorticosteroids and led to the therapeutic removal of the right adrenal gland, which showed histological signs of nodular hyperplasia.
报告了一名60岁因21-羟化酶缺乏导致未经治疗的先天性肾上腺皮质增生症的女性患者,该患者出现左肾上腺肿瘤。地塞米松可部分抑制类固醇排泄。肿瘤切除后,几种类固醇组分的排泄量大幅下降,但地塞米松的抑制作用仍不足。术前,血浆促肾上腺皮质激素(ACTh)在下午升高,给予地塞米松后仅略有下降。术后,皮质醇分泌明显减少,而促肾上腺皮质激素失调变得更加明显。负反馈失败使得无法使用低剂量糖皮质激素进行常规抑制治疗,从而导致对显示结节性增生组织学迹象的右肾上腺进行治疗性切除。